| Literature DB >> 27892500 |
Kseniya A Akulich1,2, Dmitry E Andreev3, Ilya M Terenin1,3, Victoria V Smirnova2,3, Aleksandra S Anisimova2,3, Desislava S Makeeva2,3, Valentina I Arkhipova4, Elena A Stolboushkina4, Maria B Garber4, Maria M Prokofjeva1, Pavel V Spirin1, Vladimir S Prassolov1, Ivan N Shatsky3, Sergey E Dmitriev1,3,5.
Abstract
mRNAs lacking 5' untranslated regions (leaderless mRNAs) are molecular relics of an ancient translation initiation pathway. Nevertheless, they still represent a significant portion of transcriptome in some taxons, including a number of eukaryotic species. In bacteria and archaea, the leaderless mRNAs can bind non-dissociated 70 S ribosomes and initiate translation without protein initiation factors involved. Here we use the Fleeting mRNA Transfection technique (FLERT) to show that translation of a leaderless reporter mRNA is resistant to conditions when eIF2 and eIF4F, two key eukaryotic translation initiation factors, are inactivated in mammalian cells. We report an unconventional translation initiation pathway utilized by the leaderless mRNA in vitro, in addition to the previously described 80S-, eIF2-, or eIF2D-mediated modes. This mechanism is a bacterial-like eIF5B/IF2-assisted initiation that has only been reported for hepatitis C virus-like internal ribosome entry sites (IRESs). Therefore, the leaderless mRNA is able to take any of four different translation initiation pathways in eukaryotes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27892500 PMCID: PMC5124965 DOI: 10.1038/srep37905
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Leaderless mRNA translation is relatively resistant to translation initiation inhibitors in transfected mammalian cells.
(a) Schematic representation of the Fleeting mRNA transfection procedure (FLERT). (b) Translation efficiency of the reporter mRNAs constructs. HEK293T cells were transfected with ARCA- (Anti-Reverse Cap Analog) or A-capped polyadenylated Fluc constructs having indicated 5′ leaders, along with the similarly prepared ARCA-capped Actin-Rluc mRNA. In the cIstop-Fluc construct, the 5′ terminal AUG was replaced with UAA. Fluc activity was analyzed after 2 h incubation, normalized to Rluc activity units and represented as a ratio to the value for the capped cI-Fluc mRNA. The mean absolute value for Fluc in this case was 221,805 luciferase units, Rluc – 16,238,226 units, while the background (no-transfection control) values were 60 and 150 units, respectively. Cap-dependence (i.e. ratio of translation efficiency of the ARCA- vs. A-capped mRNAs) is indicated at the bottom. (c) Schematic representation of inhibitors action on the translation initiation pathway. (d) Translation inhibition by the drugs as revealed by the FLERT technique. Luciferase activities are normalized to that in wells without the inhibitors.
Figure 2Leaderless mRNA translation is relatively resistant to selective 60 S targeting inhibitors.
(a) Schematic representation of the inhibitors action. Note that harringtonine and T-2 toxin are unable to enter elongating ribosomes and pre-associated vacant 80 S particles, while puromycin binds the ribosomes at any stage. (b) Translation inhibition by the drugs as revealed by the FLERT technique. Luciferase activities are normalized to those in wells without the inhibitors.
Figure 3Peculiar properties of the leaderless mRNA translation in the cell-free systems.
(a) Selective stimulation of the cI-Fluc mRNA translation by elevated magnesium concentration in cytoplasmic extract of Krebs-2 mouse ascites carcinoma cells. Note that only the concentration of Mg(OAc)2 in the reaction buffer is shown (without considering an endogenous Mg2+ concentration in the extract). The mean absolute values for cI-Fluc and (CAA)5cI-Fluc at 0.8 mM Mg2+ were 40,722 and 255,720 luciferase units, respectively. (b) Differential effects of the small molecule drugs and some translation initiation factors on translation of the cI-Fluc and (CAA)5cI-Fluc mRNAs in Krebs-2 cells extract (p < 0.05). Final concentrations of the additives were as follows: 1.5 mM spermidine-HCl; 250 μM NSC119889; 25 μM salubrinal; 10 ng/μl eIF1; 30 ng/μl eIF5; 50 ng/μl eIF5B. (c) Relative resistance of the leaderless mRNA translation to inhibition by recombinant eIF2αβ/aIF2γ chimeric protein in the yeast cell-free system. The luciferase activity values for the cI-Fluc mRNA were normalized to that of the (CAA)5cI-Fluc mRNA. The mean absolute values for cI-Fluc and (CAA)5cI-Fluc at the control point were 104,678 and 225,057 luciferase units, respectively. Error bars represent the standard deviations of the mean values for three independent experiments.
Figure 4The fourth translation initiation pathway for the leaderless mRNA.
(a) 48 S pre-initiation complex reconstitution from purified mammalian components on capped cIlacZ transcript. The assembled complexes were visualized by the toe-printing assay. Cross signs denote the components added to the reaction mixture. Sequencing lanes obtained with the same primer and the corresponding cDNA are shown on the left. (b) Schematic representation of four translation initiation pathways employed by the leaderless mRNA in eukaryotes.